Clinical trials
Withdrawn Phase 1 Diabetes Mellitus, Type 1 trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 2 |
| Anna Cruceta | 1 |
| Baylor Research Institute | 1 |
| Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 1 |
| Insel Gruppe AG, University Hospital Bern | 1 |
| Leilei Zhu | 1 |
| Novartis Pharmaceuticals | 1 |
| Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc. | 1 |
| Rabin Medical Center | 1 |
| Sanofi | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 1 | 13 |
| Diabetes Mellitus | 3 |
| Hypoglycemia | 2 |
| Diabetes Mellitus, Type 2 | 1 |
| Erectile Dysfunction | 1 |
| Hyperglycemia | 1 |
| Insulin Resistance | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.